Treatment of lung diseases and prelung disease conditions

Details for Australian Patent Application No. 2005245018 (hide)

Owner Transave, Inc.

Inventors Perkins, Walter; Boni, Lawrence T.; Perez-Soler, Roman; Pilkiewicz, Frank G.

Agent Shelston IP

Pub. Number AU-A-2005245018

PCT Pub. Number WO2005/112957

Priority 60/573,088 21.05.04 US

Filing date 23 May 2005

Wipo publication date 1 December 2005

International Classifications

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/112957 Priority application(s): WO2005/112957

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245021-Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1)

2005245017-Replacement of nucleus pulposus using a hydrogel